SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Espinosa Carmen) srt2:(2011-2014)"

Sökning: WFRF:(Espinosa Carmen) > (2011-2014)

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bossini-Castillo, Lara, et al. (författare)
  • A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
  • 2011
  • Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 70:4, s. 638-641
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives The aim of this study was to confirm the influence of TNFSF4 polymorphisms on systemic sclerosis (SSc) susceptibility and phenotypic features. Methods A total of 8 European populations of Caucasian ancestry were included, comprising 3014 patients with SSc and 3125 healthy controls. Four genetic variants of TNFSF4 gene promoter (rs1234314, rs844644, rs844648 and rs12039904) were selected as genetic markers. Results A pooled analysis revealed the association of rs1234314 and rs12039904 polymorphisms with SSc (OR 1.15, 95% CI 1.02 to 1.31; OR 1.18, 95% CI 1.08 to 1.29, respectively). Significant association of the four tested variants with patients with limited cutaneous SSc (lcSSc) was revealed (rs1234314 OR 1.22, 95% CI 1.07 to 1.38; rs844644 OR 0.91, 95% CI 0.83 to 0.99; rs844648 OR 1.10, 95% CI 1.01 to 1.20 and rs12039904 OR 1.20, 95% CI 1.09 to 1.33). Association of rs1234314, rs844648 and rs12039904 minor alleles with patients positive for anti-centromere antibodies (ACA) remained significant (OR 1.23, 95% CI 1.10 to 1.37; OR 1.12, 95% CI 1.01 to 1.25; OR 1.22, 95% CI 1.07 to 1.38, respectively). Haplotype analysis confirmed a protective haplotype associated with SSc, lcSSc and ACA positive subgroups (OR 0.88, 95% CI 0.82 to 0.96; OR 0.88, 95% CI 0.80 to 0.96; OR 0.86, 95% CI 0.77 to 0.97, respectively) and revealed a new risk haplotype associated with the same groups of patients (OR 1.14, 95% CI 1.03 to 1.26; OR 1.20, 95% CI 1.08 to 1.35; OR 1.23, 95% CI 1.07 to 1.42, respectively). Conclusions The data confirm the influence of TNFSF4 polymorphisms in SSc genetic susceptibility, especially in subsets of patients positive for lcSSc and ACA.
  •  
2.
  • Bossini-Castillo, Lara, et al. (författare)
  • Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
  • 2011
  • Ingår i: Rheumatology (Oxford, England). - : Oxford University Press (OUP). - 1462-0332 .- 1462-0324. ; 50, s. 1976-1981
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives. The aim of this study was to confirm the implication of macrophage migration inhibitory factor (MIF) gene in SSc susceptibility or clinical phenotypes in a large European population.Methods. A total of 3800 SSc patients and 4282 healthy controls of white Caucasian ancestry from eight different European countries were included in the study. The MIF -173 single nucleotide polymorphism (SNP) was selected as genetic marker and genotyped using Taqman 5' allelic discrimination assay.Results. The MIF -173 SNP showed association with SSc [P = 0.04, odds ratio (OR) = 1.10, 95% CI 1.00, 1.19]. Analysis of the MIF -173 polymorphism according to SSc clinical phenotype revealed that the frequency of the -173*C allele was significantly higher in the dcSSc group compared with controls (P = 5.30E-03, OR = 1.21, 95% CI 1.07, 1.38). Conversely, the frequency of the MIF -173*C allele was significantly underrepresented in the lcSSc group compared with dcSSc patients, supporting previous findings [(P = 0.04, OR = 0.86, 95% CI 0.75, 0.99); meta-analysis including previous results (P = 0.005, OR = 0.83, 95% CI 0.73, 0.94)].Conclusion. Our results confirm the role of MIF -173 promoter polymorphism in SSc, and provide evidence of a strong association with the dcSSc subgroup of patients. Hence, the MIF -173 variant is confirmed as a promising clinical phenotype genetic marker.
  •  
3.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3
Typ av publikation
tidskriftsartikel (3)
Typ av innehåll
refereegranskat (2)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Witte, Torsten (3)
Martin, Javier (3)
Nordin, Annika (3)
Hesselstrand, Roger (3)
Herrick, Ariane (3)
Worthington, Jane (3)
visa fler...
Denton, Christopher (3)
Fonseca, Carmen (3)
Riemekasten, Gabriel ... (3)
Vonk, Madelon C (3)
Beretta, Lorenzo (3)
Airó, Paolo (3)
Radstake, Timothy R ... (3)
Simeon, Carmen P. (3)
Carreira, Patricia (3)
Hunzelmann, Nicolas (3)
Kreuter, Alexander (3)
Voskuyl, Alexandre E ... (3)
Schuerwegh, Annemie ... (3)
Scorza, Raffaella (3)
Shiels, Paul (3)
van Laar, Jacob M. (3)
Espinosa, Gerard (3)
Garcia-Hernandez, Fr ... (3)
Rueda, Blanca (2)
De Langhe, Ellen (2)
Bossini-Castillo, La ... (2)
Castellvi, Ivan (2)
Koeleman, Bobby P. (2)
Palm, Oyvind (2)
Lunardi, Claudio (2)
Navarrete, Nuria (2)
Vicente-Rabaneda, Es ... (2)
Tolosa, Carlos (2)
Victoria Egurbide, M ... (2)
Fonollosa, Vicente (2)
Ortego-Centeno, Norb ... (1)
Lie, Benedicte A (1)
Koeleman, Bobby P C (1)
Westhovens, René (1)
Coenen, Marieke J. H ... (1)
Broen, Jasper C. A. (1)
Teresa Camps, Maria (1)
Gonzalez-Escribano, ... (1)
Rodriguez, Luis (1)
Roman-Ivorra, Jose A ... (1)
Gomez-Gracia, Inmacu ... (1)
Gallego, Maria (1)
Fernandez-Nebro, Ant ... (1)
Garcia-Portales, Ros ... (1)
visa färre...
Lärosäte
Lunds universitet (3)
Karolinska Institutet (3)
Språk
Engelska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)
År
2011 (3)

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy